Nugen Medical Devices Inc. (NGMDF)

Overview

NuGen Medical Devices Inc. is a specialty medical device company with a sharp focus on the development and commercialization of innovative drug delivery technologies. Positioned as a leader in the needle-free injection technology field, the company caters to a wide range of medical needs, from chronic diseases to vaccinations. NuGen's mission is to enhance the administration of subcutaneous medications, making it safer, quicker, and more comfortable for patients across various medical fields. Originally known as BuzBuz Capital Corp., NuGen has reinvented itself to address the significant need for needle-free drug delivery systems. Headquartered in Toronto, Canada, NuGen is committed to improving patient care and treatment outcomes on a global scale.

Products and Services

NuGen Medical Devices Inc. offers a comprehensive range of needle-free injection devices and systems designed to transform patient experience and improve medication administration efficiency across multiple therapeutic areas:

• Anaphylaxis: Specialized devices for rapid and needle-free administration of life-saving medications for severe allergic reactions, enhancing accessibility and user-friendliness in emergency situations.
• Diabetes: Innovations in insulin delivery for diabetes patients, allowing for painless and precise dosing, which is crucial for effective diabetes management and patient compliance.
• Severe Migraine: Delivery solutions tailored for individuals suffering from severe migraine, providing fast-acting medication administration without the distress of traditional needle-based injections.
• Erectile Dysfunction: Discreet and needle-free drug delivery systems designed for the treatment of erectile dysfunction, offering patients a less invasive and more acceptable treatment option.
• Chronic Anemia & Neutropenia: Advanced devices that facilitate the convenient administration of medication for diseases like chronic anemia and neutropenia, improving patient compliance and treatment efficacy.
• Autoimmune Rheumatoid Arthritis: Needle-free systems that deliver drugs precisely and with minimal discomfort, significantly improving the quality of life for patients with rheumatoid arthritis.
• Growth and Fertility Hormone: Cutting-edge devices for the administration of hormones related to growth and fertility treatment, enhancing ease of use and reducing the psychological barrier associated with injections.
• Psoriasis: Specialized injection devices for the treatment of psoriasis, aimed at offering a more comfortable and less intimidating medication delivery method for patients dealing with this chronic skin condition.
• DNA and Conventional/Pediatric Vaccines: Breakthrough needle-free technology for the delivery of DNA-based and conventional vaccines, including those for pediatric use, setting new standards in public health by improving vaccination rates through better patient compliance and reduced vaccine hesitancy.